The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma



Status:Active, not recruiting
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 75
Updated:12/2/2018
Start Date:November 30, 2015
End Date:March 2023

Use our guide to learn which trials are right for you!

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

This is a multicenter, randomized, open-label phase 2/3 study of Toca 511 and Toca FC versus
standard of care that comprises Investigator's choice of single agent chemotherapy (lomustine
or temozolomide) or bevacizumab administered to subjects undergoing resection for first or
second recurrence (including this recurrence) of GBM or AA. Subjects meeting all of the
inclusion and none of the exclusion criteria will be randomized prior to surgery in a 1:1
ratio to receive either Toca 511 and Toca FC (Experimental arm, Arm T) or control treatment
with one option of standard of care (Arm SOC). Stratification will be done by IDH1 mutation
status. A second stratification factor is based on the patient's Karnofsky Performance Score
(KPS) (70-80 vs 90-100). Further, to account for potential differences in treatment choices
for the control arm in regions, the trial will be stratified by geographical region during
the randomization process.

Funding Source - FDA OOPD


Inclusion Criteria:

1. Subject has given written informed consent

2. Subject is between 18 years old and 75 years old, inclusive

3. Subjects must have histologically proven GBM or AA and:

1. Must have received first-line multimodal therapy with surgery followed by
temozolomide (unless MGMT promoter unmethylated) and radiation (subjects with GBM
must have received temozolomide and radiation concurrently)

2. Must be in first or second recurrence (including this recurrence)

3. Recurrence must be confirmed by diagnostic biopsy with local pathology review or
contrast-enhanced MRI. If first recurrence of GBM is documented by MRI, an
interval of at least 12 weeks after the end of prior radiation therapy is
required unless there is either: i) histopathologic confirmation of recurrent
tumor, or ii) new enhancement on MRI outside of the radiotherapy treatment field

4. Subjects must have measurable disease preoperatively, defined as at least 1
contrast-enhancing lesion, with 2 perpendicular measurements of at least 1 cm, as per
RANO criteria

5. Subjects must be at least 4 weeks post last dose of temozolomide

6. Prior gamma knife, stereotactic radiosurgery, or other focal high-dose radiotherapy is
allowed but the subject must have either histopathologic confirmation of recurrent
tumor, or new enhancement on MRI outside of the radiotherapy treatment field

7. Based on the pre-operative evaluation by neurosurgeon, the subject is a candidate for
≥ 80% resection of enhancing region

8. IDH mutation status of the primary tumor must be available or tumor samples must be
available for pre randomization testing

9. Laboratory values adequate for patient to undergo surgery, including:

- Platelet count ≥ 60,000/mm3

- Hgb ≥ 10 g/dL

- Absolute neutrophil count (ANC) ≥ 1,500/mm3

- Absolute lymphocyte count (ALC) ≥ 500/mm3

- Adequate liver function, including:

- Total bilirubin ≤ 1.5 x ULN (unless has Gilbert's syndrome)

- ALT ≤ 2.5 x ULN f. Estimated glomerular filtration rate of at least 50
mL/min by the Cockcroft Gault formula

10. Women of childbearing potential (≥12 months of non-therapy-induced amenorrhea or
surgically sterile) must have had a negative serum pregnancy test within the past 21
days and must use a birth control method in addition to barrier methods (condoms).

11. Subject or subject's partner is willing to use condoms for 12 months after receiving
Toca 511 or until there is no evidence of the virus in his/her blood, whichever is
longer.

12. The subject has a KPS ≥ 70

13. The subject is willing and able to abide by the protocol

Exclusion Criteria:

1. History of more than 2 prior recurrences (including this recurrence) of GBM or AA

2. History of other malignancy, unless the patient has been disease free for at least 5
years. Adequately treated basal cell carcinoma or squamous cell skin cancer is
acceptable regardless of time, as well as localized prostate carcinoma or cervical
carcinoma in situ after curative treatment

3. Histologically confirmed oligodendroglioma or mixed glioma

4. Known 1p/19q co deletion

5. A contrast enhancing brain tumor that is any of the following:

- Multi focal (defined as 2 separate areas of contrast enhancement measuring at
least 1 cm in 2 planes that are not contiguous on either fluid attenuated
inversion recovery (FLAIR) or T2 sequences);

- Associated with either diffuse subependymal or leptomeningeal dissemination; or

- > 5 cm in any dimension

6. The subject has or had any active infection requiring systemic antibiotic, antifungal
or antiviral therapy within the past 4 weeks

7. The subject has any bleeding diathesis, or must take anticoagulants, or antiplatelet
agents, including nonsteroidal anti inflammatory drugs (NSAIDs), at the time of the
scheduled resection that cannot be stopped for surgery

8. The subject is human immunodeficiency virus (HIV) positive

9. The subject has a history of allergy or intolerance to flucytosine

10. The subject has a gastrointestinal disease that would prevent him or her from being
able to swallow or absorb flucytosine

11. The subject received cytotoxic chemotherapy within the past 4 weeks (6 weeks for
nitrosoureas) of the planned surgery date

12. The subject received any investigational treatment within the past 30 days or prior
immunotherapy or antibody therapy within the past 45 days.

13. The subject is pregnant or breast feeding

14. The subject intends to undergo treatment with the Gliadel® wafer at the time of this
surgery or has received the Gliadel® wafer < 30 days from W1D1 (surgery)

15. The subject has received bevacizumab for their disease unless in the context of
primary therapy for newly diagnosed glioma

16. For subjects planned to potentially receive bevacizumab, they have no evidence of
uncontrolled hypertension (defined as a blood pressure of ≥ 150 mm Hg systolic and/or
≥ 100 mm Hg diastolic on medication) or active GI perforation

17. The subject has received systemic dexamethasone continuously at a dose > 8 mg/day for
8 weeks prior to the date of the screening assessment

18. Severe pulmonary, cardiac or other systemic disease, specifically:

- New York Heart Association > Grade 2 congestive heart failure within 6 months
prior to study entry, unless asymptomatic and well controlled with medication

- Uncontrolled or significant cardiovascular disease, clinically significant
ventricular arrhythmia (such as ventricular tachycardia, ventricular
fibrillation, or Torsades des pointes), clinically significant pulmonary disease
(such as ≥ Grade 2 dyspnea, according to CTCAE 4.03)

- Subjects who have any other disease, either metabolic or psychological, which as
per Investigator assessment may affect the subject's compliance or place the
subject at higher risk of potential treatment complications
We found this trial at
51
sites
Evanston, Illinois 60201
Principal Investigator: Ryan Merrell, MD
Phone: 847-570-2025
?
mi
from
Evanston, IL
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Michael Vogelbaum, MD
Phone: 216-444-7937
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
3500 Gaston Avenue
Dallas, Texas 75246
1.800.422.9567
Principal Investigator: Karen Fink, MD, PhD
Phone: 214-820-6168
Baylor University Medical Center Baylor University Medical Center in Dallas, TX is ranked nationally in...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Los Angeles, California 90095
310-825-4321
Principal Investigator: Timothy Cloughesy, MD
Phone: 310-794-3521
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Miami, Florida 33124
(305) 284-2211
Principal Investigator: Antonio Omuro, MD
Phone: 305-243-9610
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: Clark Chen, MD
Phone: 612-626-2569
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Reid C Thompson, MD
Phone: 615-936-8606
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
116th St and Broadway
New York, New York 10027
(212) 854-1754
Principal Investigator: Fabio Iwamoto, MD
Phone: 212-305-8487
Columbia University In 1897, the university moved from Forty-ninth Street and Madison Avenue, where it...
?
mi
from
New York, NY
Click here to add this to my saved trials
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Principal Investigator: Steven Brem, M.D.
Phone: 215-662-6832
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
601 Elmwood Avenue
Rochester, New York 14642
(585) 275-2100
Principal Investigator: Nimish Mohile, MD
Phone: 585-276-3971
Univ of Rochester Medical Center One of the nation's top academic medical centers, the University...
?
mi
from
Rochester, NY
Click here to add this to my saved trials
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
Principal Investigator: Jason Heth, MD
Phone: 734-615-1749
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Aurora, Colorado 80045
Principal Investigator: Denise Damek, MD
Phone: 720-848-7202
?
mi
from
Aurora, CO
Click here to add this to my saved trials
733 North Broadway
Baltimore, Maryland 21205
(410) 955-3182
Principal Investigator: Chetan Bettegowda, MD, PhD
Phone: 410-502-4081
Johns Hopkins University School of Medicine Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: David Cachia, MD
Phone: 843-792-2209
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
1215 Lee St
Charlottesville, Virginia 22903
(434) 924-0211
Principal Investigator: David Schiff, MD
Phone: 434-243-9360
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cincinnati, Ohio 45229
Principal Investigator: Mariko DeWire, MD
Phone: 513-636-2047
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio 44012
Principal Investigator: Andrew E Sloan, MD
Phone: 216-844-5071
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Principal Investigator: Brad J Elder, MD
Phone: 614-293-6563
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Detroit, Michigan 48202
Principal Investigator: Tobias Walbert, MD
Phone: 313-916-1736
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Edison, New Jersey 08820
Principal Investigator: Joseph Landolfi, D.O.
Phone: 732-321-7000
?
mi
from
Edison, NJ
Click here to add this to my saved trials
Edmonton, Alberta T6G 2J2
Principal Investigator: Vivek Mehta, MD
Phone: 780-248-5803
?
mi
from
Edmonton,
Click here to add this to my saved trials
Englewood, Colorado
Principal Investigator: Michael Pearlman, MD, PhD
Phone: 303-357-5446
?
mi
from
Englewood, CO
Click here to add this to my saved trials
Fairfax, Virginia 22031
Principal Investigator: James Leiphart, MD
Phone: 703-269-4759
?
mi
from
Fairfax, VA
Click here to add this to my saved trials
Fairfield, Connecticut 06824
Principal Investigator: Nicholas Blondin, MD
Phone: 203-333-1151
?
mi
from
Fairfield, CT
Click here to add this to my saved trials
Gainesville, Florida 32610
Principal Investigator: David Tran, MD, PhD
Phone: 352-273-7981
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hackensack, New Jersey 07601
Principal Investigator: George J Kaptain, MD
Phone: 551-996-5098
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Jay-Jiguang Zhu, MD, PhD
Phone: 713-704-2639
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: David Baskin, MD, FACS
Phone: 713-441-3800
?
mi
from
Houston, TX
Click here to add this to my saved trials
Irvine, California 92697
949-824-5011
Principal Investigator: Daniela Bota, MD PhD
Phone: 714-509-2371
University of California, Irvine Since 1965, the University of California, Irvine has combined the strengths...
?
mi
from
Irvine, CA
Click here to add this to my saved trials
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Principal Investigator: Michael Salacz, MD
Phone: 913-945-7690
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
Kansas City, Missouri 64132
Principal Investigator: Amandeep Kalra, MD
Phone: 816-276-9786
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
9500 Gilman Dr
La Jolla, California 92093
(858) 534-2230
Principal Investigator: David Piccioni, MD
Phone: 858-534-7996
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
Lake Success, New York 11042
Principal Investigator: Michael Schulder, M.D.
Phone: 516-941-1263
?
mi
from
Lake Success, NY
Click here to add this to my saved trials
Madison, Wisconsin 53792
(608) 263-2400
Principal Investigator: John Kuo, MD, PhD
Phone: 608-262-8649
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
?
mi
from
Madison, WI
Click here to add this to my saved trials
Minneapolis, Minnesota 55407
Principal Investigator: John Trusheim, MD
Phone: 612-863-6562
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Morgantown, West Virginia 26506
(304) 293-0111
Principal Investigator: Christopher Cifarelli, MD
Phone: 304-293-1683
West Virginia University West Virginia University, founded in 1867, has a long and rich history...
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
New Haven, Connecticut 06520
Principal Investigator: Jennifer Moliterno Gunel, MD
Phone: 203-737-7981
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York 10021
Principal Investigator: Rohan Ramakrishna, MD
Phone: 212-746-7373
?
mi
from
New York, NY
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: Dimitris Placantonakis, MD, PhD
Phone: 212-263-4414
?
mi
from
New York, NY
Click here to add this to my saved trials
Norfolk, Virginia 23507
Principal Investigator: Wylie H Zhu, MD, PhD
Phone: 757-388-2533
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Principal Investigator: Nicole A Shonka, MD
Phone: 402-559-6745
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orange, California 92868
Principal Investigator: Lars Anker, M.D.
Phone: 714-734-6200
?
mi
from
Orange, CA
Click here to add this to my saved trials
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Principal Investigator: Lyndon Kim, MD
Phone: 215-503-5646
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
350 West Thomas Road
Phoenix, Arizona 85013
Principal Investigator: Nader Sanai, M.D.
Phone: 602-406-6267
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Principal Investigator: Jian Campian, MD
Phone: 314-273-0656
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Nicholas Butowski, MD
Phone: 415-353-2582
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
Sioux Falls, South Dakota 65104
Principal Investigator: Miroslaw Mazurczak, MD
Phone: 605-328-1361
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
450 Serra Mall
Stanford, California 94305
(650) 723-2300
Principal Investigator: Seema Nagpal, MD
Phone: 650-723-4467
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Stony Brook, New York 11794
Principal Investigator: Raphael Davis, MD
Phone: 631-444-9425
?
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Summit, New Jersey 07901
Principal Investigator: Yaron Moshel, MD
Phone: 908-522-5768
?
mi
from
Summit, NJ
Click here to add this to my saved trials
Tampa, Florida 33612
Principal Investigator: Nam Tran, MD, PhD
Phone: 813-745-1194
?
mi
from
Tampa, FL
Click here to add this to my saved trials